1.22 USD
↘ 0.17 (12.00%)AT CLOSE (03:59 PM EDT)
MetaVia Inc. Common Stock
MTVANASDAQ • USD
1.28
↗ 0.06 (4.94%)
POST MARKET (AS OF 04:51 PM EDT)
Post Market
AS OF 04:51 PM EDT
1.28
↗ 0.06 (4.94%)
Market: OPEN
MetaVia Inc. Common Stock (MTVA) trades at $1.28 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest MTVA is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 23, 2026.
Open?$1.41
High?$1.41
Low?$1.22
Prev. Close?$1.38
Volume?135.8K
Avg. Volume?61.0K
VWAP?$1.29
Rel. Volume?2.23x
Bid / Ask
Bid?$1.06 × 100
Ask?$1.41 × 100
Spread?$0.35
Midpoint?$1.23
Valuation & Ratios
Market Cap?9.1M
Shares Out?5.2M
Float?3.4M
Float %?65.2%
P/E Ratio?N/A
P/B Ratio?1.33
EPS?-$2.19
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. Vanoglipel (DA-1241) is a novel GPR119 (GPR119) agonist with development optionality as a standalone or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). Agonism of GPR119 in the gut promotes the release of key gut peptides, glucagon-like peptide-1 (GLP-1), glucagon-dependent insulinotropic polypeptide receptor (GIP), and peptide YY.
Address
545 CONCORD AVENUE
CAMBRIDGE, MA 02138
Phone: (857) 702-9600
CAMBRIDGE, MA 02138
Phone: (857) 702-9600
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?65
Piotroski F-Score?0/9Weak
Altman Z-Score?-18.92Distress
Confidence?42%Low
Short InterestLow
Short % of Float?3.49%Low
Short Interest?117.4K
Days to Cover?2.0
Free Float3.4M
Avg Daily Volume57.8K
Settlement Date2026-09-30
Financial Health
Current Ratio?2.06Strong
Quick Ratio?2.06Strong
Cash Ratio?1.99Strong
Debt/Equity?0.42Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.33CHEAP▾
Peers100
S&P91
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.1CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-211.8%WEAK▾
S&P3
ROA?-108.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-15835000
Enterprise Value?$-694421
Fundamentals ratios updated end of day